Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

BNDX vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, BNDX returned −0.9% to IBB's +37.5%, and BNDX charges 0.07% to IBB's 0.44%.

askIQ about this page

askIQ about BNDX and IBB

Net assets: $82.9bn on Sep 30, 2026 for Vanguard Total International Bond ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
−0.9%
BNDX total return, 1 year
+37.5%
IBB total return, 1 year
0.07%
BNDX expense ratio
0.44%
IBB expense ratio

Pair scorecard

BNDX costs 0.37 points a year less; their one-year returns differ by 38.4 points; BNDX is 7.4 times larger.

BNDX vs IBB: Differences, Returns & Fees
MeasureBNDXIBB
Return
Total return, 1 year−0.9%+37.5%
Benchmark
What it tracksBloomberg Global Aggregate ex-USD Float Adjusted RIC Capped Index (USD Hedged)Biotech
Cost and size
Expense ratio0.07%0.44%
Net assets, as of Sep 30, 2026$82.9bn$11.2bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
In the S&P 500, by weight40%
Top ten holdings, share of the fund50%

Holdings in common uses holdings dated Sep 30, 2026 and Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, BNDX and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Sep 30, 2026 and Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first BNDX IBB
Only in one fund ↓
Only in BNDX
MKTLIQ 0.93%
United Kingdom Gilt 0.39%
French Republic Government Bond OAT 0.35%
United Kingdom Gilt 0.35%
French Republic Government Bond OAT 0.35%
United Kingdom Gilt 0.34%
United Kingdom Gilt 0.33%
French Republic Government Bond OAT 0.31%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

BNDX Vanguard Total International Bond ETF IBB iShares Biotechnology ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of Total International Bond Biotech
Total return, 1 year −0.9% +37.5%
Expense ratio 0.07% 0.44%
Holdings 6840 245
Net assets, BNDX as of Sep 30, 2026 and IBB as of Oct 27, 2026 $82.9bn $11.0bn

BNDX and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
BNDX

BNDX tracks an index of Total International Bond. Over the year to Oct 28, 2026 it returned −0.9% with distributions reinvested. The prospectus expense ratio is 0.07% a year.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are BNDX and IBB in the same category?
BNDX is a bond ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, BNDX or IBB?
In the year to Oct 28, 2026, with distributions reinvested, BNDX returned −0.9% and IBB +37.5%.
Which is cheaper, BNDX or IBB?
BNDX is cheaper, by 0.37 percentage points a year. That is about $37 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, BNDX against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/bndx-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.